• Aucun résultat trouvé

Development of an in vivo phosphorylation system in Escherichia coli

N/A
N/A
Protected

Academic year: 2021

Partager "Development of an in vivo phosphorylation system in Escherichia coli"

Copied!
1
0
0

Texte intégral

(1)

Development of an in vivo phosphorylation

system in Escherichia coli

Goux M.

1,2

, Defontaine A.

1

, Fateh A.

1

, Cinier M.

2

and Tellier C.

1

1

UFIP, University of Nantes, France and

2

Affilogic SAS, Nantes, France

FRE CNRS 3478

Unité Fonctionnalité et Ingénierie des Protéines 2 rue de la Houssinière 44322 Nantes France

AFFILOGIC SAS

2 rue de la Houssinière 44322 Nantes France

Contact : marine.goux@univ-nantes.fr

2

nd

NanoFar

Autumn School

October 21-25, 2013 University of Santiago de Compostella, Spain

References : [1] Heuveling D. A. et al. (2011), Oral Oncology, 47, pp. 2–7 ; [2] Cinier

M. et al. (2012), Journal of Biological Inorganic Chemistry, 17, pp. 399–407 ; [3]

PhosphoProtein Handbook (2011), QIAGEN® ; [4] Machida M. et al. (2007), FEBS

Journal, 274, pp. 1576–1587

3. Optimization of the phosphorylation

Arabinose 0.2% IPTG 0.5mM

ATP 5mM after lysis

+ + -+ + + Coomassie blue staining ProQDiamond® staining

Extra addition of ATP after lysis improve significantly the rate of phosphorylation.

Recently, new strategies emerged in the field of monoclonal antibodies radiolabeling for PET imaging with the use of positron emitter such as zirconium-89 or gallium-68[1]. Despite their important role in the therapeutic world,

antibodies have many disadvantages related to their structure. Moreover, conjugation of chelating agent often occurs on lysines, which is non-regioselective and leads to a heterogeneous mixture of products. In addition, the slow clearance of antibodies can be a problem to obtain a good contrast when they are used in imaging.

To address these different limitations, we developed a chemistry-free chelating system consisting of a highly

phosphorylatable peptide tag. A specific phosphorylation step, with the alpha subunit of the casein kinase II

(CKIIα), generates a nanocluster of four phosphates that can interact strongly with metal ions like zirconium. This strategy has already demonstrated its powerfulness for the stable and specific anchoring of protein on zirconium phosphonate-based microarray[2]. We are now adapting the use of this labeling tag to the stereoselective chelation of

radionuclides for PET imaging. To ensure an efficient targeting of the radionuclide, the tag was genetically fused to a

Nanofitin®, a protein scaffold developed as an alternative to antibodies.

1. Chelation of the peptide tag with

terbium(III) and zirconium(IV)

In order to optimize the sequence of the phosphorylatable tag, we studied the chelation of different mimetic peptides with terbium(III). The chelation of the zirconium by the peptide tag was confirmed by a competition study.

Arabinose 0.2% IPTG 0.5mM -+ -+ + + T- T+ Coomassie blue staining ProQDiamond® staining

Effectiveness of the in vivo system was demonstrated both by electrophoretic mobility shift assay and staining with a specific phosphoprotein staining gel:

ProQDiamond®.

2. Co-expression system TOP10/pNF-pCKIIα

TOP10

pNF

pCKIIα

Promotor : T5 Induction : IPTG Resistance : Ampicilline Promotor : araBAD Induction : arabinose Resistance : Chloramphenicol

In early development, the phosphorylation was realized in

vitro. In order to save purification steps and decrease

production costs, we developed an in vivo phosphorylation

system consisting in the co-expression of a Nanofitin® fused to

the phosphorylatable tag (pNF) and the CKIIα.

5. Purification of the phosphorylated

Nanofitin® by Fe-NTA and Ga-NTA

4. Evaluation of the phosphorylation rate by

isoelectric focusing

Using the specific interaction of phosphate moeity with gallium(III) or iron(III), we are currently developing a phosphoprotein purification protocol by immobilized metal affinity chromatography[3,4].

The isoelectric focusing method is based on the fact that the pHi of the Nanofitin® decreases as the protein is phosphorylated. Such a technique allowed us to isolate the different phosphorylation states of the phospho-Nanofitin® (from 0

to 4 phospho-serine).

pH3 pH10

Fluorescence increases as the

peptide is phosphorylated. Fluorescence decreases in presenceof zirconium.

0 1000 2000 3000 4000 5000 6000 7000 0 0,25 0,5 0,75 1 Fl u o res cenc e (AU )

Equivalent of terbium per peptide

Terbium(III) titration of mono- and tetra-phosphorylated peptides in formic acid pH2

(After removal of peptides and terbium fluorescence)

Tetra-phosphorylated peptide Mono-phosphorylated peptide

0 500 1000 1500 2000 2500 3000 3500 0 0,25 0,5 0,75 1 Fl u o res cenc e (AU )

Equivalent of terbium or terbium/zirconium (1:1) per peptide

Terbium(III) titration of tri-phosphorylated peptide and competition with zirconium(IV)

in formic acid pH2

(After removal of peptide and terbium fluorescence)

Tri-phosphorylated peptide + TbCl3 Tri-phosphorylated peptide + TbCl3/ZrOCl2 (1:1)

3P 4P 0P Nanofitin® (pHi 5,35) PhosphoNanofitin® Zr Nanofitin® Nanofitin®

Références

Documents relatifs

S'ils se blessent aussi c'est pour se préserver d'une souffrance qu'ils traînent et répètent comme si elle était imprégnée dedans.. L'orientation à un travail pourrait se

Pour lutter contre la stigmatisation, il faut axer les démarches sur deux domaines : diminuer les actions stigmatisantes de la population, ainsi que du personnel médical et

(1981) displace- ment along the Simplon normal fault (Mancktelow 1990) is additionally transformed into the southern limb of Van- zone and Brevettola antiforms, where D4 folding is

As a consequence of the changes, described earlier, in bile acid availability in the lumen of the intestines, the amount of dietary cholesterol absorbed was about 9 mg/mouse per

An implementation of the Kubelka-Munk model combined with Saunderson correction allows measuring six parameters of Caucasian skin: epidermis thickness, melanin volume fraction,

Visualisation by vital staining with trypan blue of wounds punctured by Varroa destructor mites in pupae of the honey bee (Apis mellifera)...

Nonsteroidal anti- inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.. Solene Doat 1,2 , Sylvie Cénée 1 , Brigitte Trétarre 3 , Xavier Rebillard 4